Graphic representation of the relationship between zinc deficiency, Crohn’s Disease and Ulcerative Colitis (from Zupo R, et al. Nutrients. 2022)
One
in every two people with irritable bowel disease (IBD) is zinc-deficient,
according to a recent systematic review of nine studies representing more than
2,400 IBD patients.
The
prevalence of zinc deficiency, based on serum zinc measurements, was higher
among those with Crohn’s disease (CD), affecting 54% of the patients in this
subgroup, versus 41% of those with ulcerative colitis (UC).
“This
is the first meta-analytic study to be conducted on the prevalence of zinc
deficiency in IBD,” wrote lead author Roberta Zupo, at the Saverio de Bellis
National Institute of Gastroenterology, Castellana Grotte, Italy. “The present
research highlights the importance of considering zinc as a micronutrient to be
monitored, because every second IBD patient shows a deficiency.”
With the release of its long-awaited Standard Operating Procedure for Disposal/Destruction of Irreparably Defective Articles in November, the Botanical Adulterants Prevention Program (BAPP) has taken a major step forward in its ongoing effort to rid the nutrition and herbal medicine industries of adulterated or otherwise fraudulent ingredients. The “BAPP SOP” guidelines, as the new document […]
Research on medicinal herbs and phytochemicals continues to surge worldwide. Here are summaries of a few of the recent studies that grabbed our attention here at Holistic Primary Care. Horsetail Extract Matches Thiazide for BP Regulation A standardized extract of Horsetail (Equisetum arvense) produced clinically and statistically significant reductions in both systolic and diastolic blood […]
Hormone
Replacement Therapy & Bone Health: Cyplexinol Nutritional Support
On
average bone density decreases by 10% in women during the five years of
menopause due to changes in estrogen. While Hormone Replacement Therapy offers
support in maintaining bone health, there can be a precipitous loss when women
discontinue HRT.
Along
with the decline in estrogen, there is a concurrent 40% drop in production
of bone-stimulating Growth
Factor Proteins in the menopausal period, which can lead to dysregulation of
bone remodeling.
While
HRT is well-established for estrogen support, there’s a largely unmet need to
address this decline of Growth Factor Proteins.
In this free webinar, women’s health expert Jaquel
Patterson, ND, will explore how a nutraceutical called Cyplexinol®–a growth
factor complex patented for osteoinductive properties–can be used support HRT
protocols for improved bone density outcomes.
Discover
how the
age-related decreases in estrogen and Growth Factor Proteins affect women’s bone health, and the nutritional
interventions you can provide to support healthy bone remodeling.
Jaquel Patterson, ND, MBA is the founder and medical director of Fairfield Family Health, an integrative medicine clinic in Fairfield, CT. Dr. Patterson is a nationally-recognized naturopathic physician, specializing in Lyme disease, autoimmune conditions, anxiety/depression, childhood developmental disorders, and women’s health. She received her ND degree from the University of Bridgeport College of Naturopathic Medicine, and earned an MBA in healthcare administration from Quinnipiac University. She is a past-president of the American Association of Naturopathic Physicians, and a popular author and speaker for many health and fitness media outlets.
